Display Settings:

Format

Send to:

Choose Destination

    J Infect Dis. 1997 Aug;176(2):439-44.

    Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia.

    van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF.

    Department of Surgery, Cornell University Medical College, New York, New York, USA.

    Induction of pneumonia in C57Bl/6 mice by intranasal inoculation with 10(6) cfu of Streptococcus pneumoniae resulted in sustained expression of interleukin (IL)-6 mRNA in lungs and increases in lung and plasma IL-6 concentrations. In IL-6-deficient (IL-6-/-) mice, pneumonia was associated with higher lung levels of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1beta, and interferon-gamma and of the antiinflammatory cytokine IL-10 than in wild type (IL-6+/+) mice (all P < .05). Also, the plasma concentrations of soluble tumor necrosis factor receptors were higher in IL-6-/- mice (P < .05), while the acute-phase protein response was strongly attenuated (P < .01). Lungs harvested from IL-6-/- mice 40 h after inoculation contained more S. pneumoniae colonies (P < .05). IL-6-/- mice died significantly earlier from pneumococcal pneumonia than did IL-6+/+ mice (P < .05). During pneumococcal pneumonia, IL-6 down-regulates the activation of the cytokine network in the lung and contributes to host defense.

    PMID: 9237710 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read